<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cell Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Cell. Mol. Med</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1582-4934</journal-id>
<journal-id journal-id-type="publisher-id">JCMM</journal-id>
<journal-title-group>
<journal-title>Journal of Cellular and Molecular Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1582-1838</issn>
<issn pub-type="epub">1582-4934</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27748550</article-id>
<article-id pub-id-type="pmc">5345638</article-id>
<article-id pub-id-type="doi">10.1111/jcmm.13009</article-id>
<article-id pub-id-type="publisher-id">JCMM13009</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A promoter polymorphism rs2075824 within <styled-content style="fixed-case">IMPA</styled-content>2 gene affecting the transcription activity: possible relationship with schizophrenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="jcmm13009-cr-0001">
<name>
<surname>Li</surname>
<given-names>Jia</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="jcmm13009-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13009-cr-0002">
<name>
<surname>Huang</surname>
<given-names>Sheng</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="jcmm13009-note-1001">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13009-cr-0003">
<name>
<surname>Dai</surname>
<given-names>Hui‐Rong</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13009-cr-0004">
<name>
<surname>Wang</surname>
<given-names>Juan</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13009-cr-0005">
<name>
<surname>Lin</surname>
<given-names>Li‐Hui</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13009-cr-0006">
<name>
<surname>Xiao</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13009-cr-0007">
<name>
<surname>Peng</surname>
<given-names>Xia</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13009-cr-0008">
<name>
<surname>Li</surname>
<given-names>Fei</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="jcmm13009-cr-0009">
<name>
<surname>Wang</surname>
<given-names>Yu‐Ping</given-names>
</name>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="jcmm13009-cr-0010">
<name>
<surname>Yuan</surname>
<given-names>Jian‐Min</given-names>
</name>
<address>
<email>13358118723@163.com</email>
</address>
<xref ref-type="aff" rid="jcmm13009-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="jcmm13009-cr-0011">
<name>
<surname>Li</surname>
<given-names>Li</given-names>
</name>
<address>
<email>annylish@hotmail.com</email>
</address>
<xref ref-type="aff" rid="jcmm13009-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="jcmm13009-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Laboratory Medicine</named-content>
<named-content content-type="organisation-division">School of Medicine</named-content>
<named-content content-type="organisation-division">Shanghai General Hospital</named-content>
<institution>Shanghai JiaoTong University</institution>
<named-content content-type="city">Shanghai</named-content>
<country country="CN">China</country>
</aff>
<aff id="jcmm13009-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Central Laboratory</named-content>
<institution>Wuxi Mental Health Center</institution>
<named-content content-type="city">Wuxi</named-content>
<named-content content-type="country-part">Jiangsu</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>
Correspondence to: Jian‐Min YUAN<break></break>
E‐mail: <email>13358118723@163.com</email><break></break>
Dr. Li LI<break></break>
E‐mail: <email>annylish@hotmail.com</email><break></break></corresp>
<fn fn-type="equal" id="jcmm13009-note-1001">
<label>†</label>
<p>Equal contributors.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2017</year>
</pub-date>
<volume>21</volume>
<issue>4</issue>
<issue-id pub-id-type="doi">10.1111/jcmm.2017.21.issue-4</issue-id>
<fpage>658</fpage>
<lpage>664</lpage>
<history>
<date date-type="received">
<day>02</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>9</month>
<year>2016</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:JCMM-21-658.pdf" xlink:type="simple"></self-uri>
<abstract id="jcmm13009-abs-0001">
<title>Abstract</title>
<p>Previous studies with biological and genetic evidence indicate that the myo‐inositol monophosphatase 2 (<italic><styled-content style="fixed-case">IMPA</styled-content>2</italic>) gene may influence schizophrenia. We performed a genetic association study in Han Chinese cohorts. Five single nucleotide polymorphisms within <styled-content style="fixed-case">IMPA</styled-content>2 promoter region (rs971363, rs971362, rs2075824, rs111410794 and rs111610121), as well as one (rs45442994, in intron 1) that was positively associated in another study, were selected for genotyping in 1397 patients with schizophrenia and 1285 mentally healthy controls. Genotype and allele frequencies were assessed by gender stratification. Interestingly, rs2075824 showed a strong association with schizophrenia (<italic>P</italic> = 4.1 × 10<sup>−4</sup>), and the T allele was more frequent in cases than controls [<italic>P</italic> = 5.6 × 10<sup>−5</sup>, <styled-content style="fixed-case">OR</styled-content> (95% <styled-content style="fixed-case">CI</styled-content>) = 1.26 (1.13–1.41)]. In vitro promoter assay showed that the transcription activity of the T allele promoter was higher than that of the C allele promoter and the T allele of rs2075824 contributed to risk for schizophrenia. By stratifying males and females, we found a gender‐specific association for <italic><styled-content style="fixed-case">IMPA</styled-content>2</italic> and schizophrenia: the T allele of rs2075824 was more frequent in male cases compared with male controls [<italic>P</italic> = 1.4 × 10<sup>−4</sup>, <styled-content style="fixed-case">OR</styled-content> (95% <styled-content style="fixed-case">CI</styled-content>) = 1.33 (1.15–1.55)]. Our data suggest that a promoter polymorphism of <italic><styled-content style="fixed-case">IMPA</styled-content>2</italic> possibly contributed to risk for schizophrenia by elevating transcription activity in Han Chinese individuals.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="jcmm13009-kwd-0001">myo‐inositol monophosphatase 2</kwd>
<kwd id="jcmm13009-kwd-0002">schizophrenia</kwd>
<kwd id="jcmm13009-kwd-0003">Han Chinese</kwd>
<kwd id="jcmm13009-kwd-0004"><styled-content style="fixed-case">SNP</styled-content>s</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Science Foundation of China</funding-source>
<award-id>81273276</award-id>
<award-id>81302551</award-id>
<award-id>81471593</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Clinical Auxiliary Departments Construction Project of Shanghai Shen‐Kang Hospital Development Center</funding-source>
<award-id>SHDC22014005</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Shanghai Natural Science</funding-source>
<award-id>14411963200</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>Shanghai Municipal Science and Technology</funding-source>
<award-id>15431901900</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="5"></table-count>
<page-count count="7"></page-count>
<word-count count="5137"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>jcmm13009</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>April 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.8 mode:remove_FC converted:10.03.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="jcmm13009-sec-0001">
<title>Introduction</title>
<p>Schizophrenia (SCZ) is characterized by a constellation of chronic symptoms including hallucinations, delusions, social and occupational deterioration, and affects approximately 1% of the population worldwide <xref ref-type="ref" rid="jcmm13009-bib-0001">1</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0002">2</xref>. Linkage studies have revealed that SCZ and bipolar disorder share a number of overlapping features and genetic risk variants <xref ref-type="ref" rid="jcmm13009-bib-0003">3</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0004">4</xref>. Bipolar disorder is associated with neurocognitive deficits that persist into euthymia after episode resolution <xref ref-type="ref" rid="jcmm13009-bib-0005">5</xref>. Several meta‐analyses have revealed impairments in the broad domains of attention, processing speed, verbal memory and executive functions, with relative preservation of verbal abilities and intelligence. This pattern of deficits is similar to that in SCZ, although less severe in magnitude <xref ref-type="ref" rid="jcmm13009-bib-0006">6</xref>. One locus, 18p11.2, was identified decades ago as a susceptibility locus for both disorders <xref ref-type="ref" rid="jcmm13009-bib-0007">7</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0008">8</xref>, and has since been confirmed in other studies <xref ref-type="ref" rid="jcmm13009-bib-0009">9</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0010">10</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0011">11</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0012">12</xref>. Myo‐inositol monophosphatase 2 (<italic>IMPA2</italic>) is a candidate gene in this region which was identified by Yoshikawa <italic>et al</italic>. <xref ref-type="ref" rid="jcmm13009-bib-0013">13</xref>. Subsequently, other studies in different ethnic groups verified the relationship between <italic>IMPA2</italic> and SCZ and bipolar disorder <xref ref-type="ref" rid="jcmm13009-bib-0014">14</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0015">15</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0016">16</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0017">17</xref>. Furthermore, Yoon <italic>et al</italic>. reported that <italic>IMPA2</italic> showed gender‐dependent expression differences in the brains of patients with bipolar disorder <xref ref-type="ref" rid="jcmm13009-bib-0018">18</xref>. Recently, Ramsey <italic>et al</italic>. proposed to investigate the gender‐specific etiologies of SCZ <xref ref-type="ref" rid="jcmm13009-bib-0019">19</xref>; however, to our knowledge no study to date has performed a gender‐specific analysis between <italic>IMPA2</italic> and SCZ. This prompted us to examine the contribution of IMPA2 to SCZ in Han Chinese cohorts.</p>
</sec>
<sec id="jcmm13009-sec-0002">
<title>Materials and methods</title>
<sec id="jcmm13009-sec-0003">
<title>Subjects</title>
<p>1397 unrelated individuals with SCZ and 1285 controls were included in this study. No significant differences were found with respect to population characteristics between the two groups (Table <xref ref-type="table-wrap" rid="jcmm13009-tbl-0001">1</xref>). The cases were inpatients or outpatients from Wuxi Mental Health Center identified on the basis of previously established criteria: (<italic>i</italic>) patients met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM‐IV) criteria for SCZ <xref ref-type="ref" rid="jcmm13009-bib-0020">20</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0021">21</xref>, and the diagnoses were confirmed by two independent psychiatrists who reviewed all medical records of the patients, interviewed collateral informants (most often clinical staffs), and used information from recent interviews with the patients; (<italic>ii</italic>) patients had no physical disease or other psychiatric disorder apart from SCZ. Controls were randomly selected from the Shanghai general population and were all interviewed by professional psychiatrists using the Structured Clinical Interview for DSM‐ IV (a diagnostic exam used to determine DSM‐IV disorders, the instrument was designed to be administered by a mental health professional, for example a psychologist or psychiatrist.) to exclude a history of psychiatric disorders, chronic neurological disease, and family history of psychiatric disorders.</p>
<table-wrap id="jcmm13009-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Characteristics of schizophrenia patients and controls</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Variable</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>n</italic>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">Age (mean ± S.D., years)</th>
<th align="char" colspan="1" rowspan="1" valign="top">Gender, female:male</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">SCZ group</td>
<td align="char" colspan="1" rowspan="1">1397</td>
<td align="char" char="±" colspan="1" rowspan="1">46.7 ± 12.2</td>
<td align="char" colspan="1" rowspan="1">556:841</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CTR group</td>
<td align="char" colspan="1" rowspan="1">1285</td>
<td align="char" char="±" colspan="1" rowspan="1">44.7 ± 11.1</td>
<td align="char" colspan="1" rowspan="1">559:726</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<italic>P</italic>‐value</td>
<td align="char" colspan="1" rowspan="1">–</td>
<td align="char" colspan="1" rowspan="1">0.471</td>
<td align="char" colspan="1" rowspan="1">0.052</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="jcmm13009-note-0002">
<p>SCZ: schizophrenia; CTR: control.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>The study protocol was approved by the Ethics Committee of Shanghai First People's Hospital, and was conducted in agreement with the Declaration of Helsinki Principles <xref ref-type="ref" rid="jcmm13009-bib-0022">22</xref>. Informed written consent was obtained from all participants. We used the following criteria to evaluate whether the participants had the capacity to consent: (<italic>i</italic>) patient's ability to understand; (<italic>ii</italic>) patient's ability to reason; and (<italic>iii</italic>) patient's ability to make rational decisions. If participants failed to fill out the consent form more than twice, their guardians were asked to fill out the consent form on the patients' behalf.</p>
</sec>
<sec id="jcmm13009-sec-0004">
<title>DNA extraction</title>
<p>Blood samples were collected from all participants using K<sub>2</sub>EDTA tubes. Genomic DNA was extracted from peripheral leucocytes by standard procedures using a Genomic DNA kit (Axygen, Hangzhou, China) and then stored at −80°C for genotype analysis.</p>
</sec>
<sec id="jcmm13009-sec-0005">
<title>SNP selection and genotyping</title>
<p>Five single nucleotide polymorphisms (SNPs) within IMPA2 promoter region (rs971363, rs971362, rs2075824, rs111410794 and rs111610121), as well as rs45442994 in intron 1 were selected for case–control analysis. Genotyping of six polymorphisms was performed using PCR and ligase detection reaction (LDR). PCR primers and LDR probes were synthesized by Invitrogen (Shanghai, China) and the sequences are available (see Tables S1 and S2). For PCR, 1 μl of each DNA sample was added to 19 μl of PCR mixture containing 1× PCR buffer, 1× Q‐Solution (Qiagen, Hilden, Germany), 3 mmol/l MgCl<sub>2</sub>, 0.2 mmol/l of each dNTP, 50 pmol/μl primers, and 1 U of HotStar Taq polymerase (Qiagen). PCR cycling conditions were: pre‐denaturation at 95°C for 2 min., denaturation at 94°C for 30 sec., anneal at 56°C for 90 sec., and extend at 72°C for 60 sec., the application was performed for 35 cycles, and a final 10 min. extension step at 65°C. PCR products were observed by agarose gel electrophoresis (3.0%), visualized with ImageMaster VDS (Pharmacia Biotech, Piscataway, NJ, USA), and then used as templates in LDR. LDR reactions were carried out in 10 μl reaction mixtures consisting of 1× Buffer, 2 pmol/μl Probe mix, 2 U NEB Taq DNA ligase, and 100 ng/μl PCR product. The reaction program was performed as follows: an initial heating at 95°C for 2 min., followed by 40 cycles (94°C for 15 sec. and 50°C for 25 sec.). The products were submitted for sequencing on a PRISM 3730 (ABI) sequencer, and the results were analysed with GeneMapper software, version 3.3 (Applied Biosystems Incorporation, Foster City, CA, USA).</p>
</sec>
<sec id="jcmm13009-sec-0006">
<title>Plasmid construction</title>
<p>Reporter plasmids carrying luciferase gene under the control of IMPA2 promoter with rs2075824 C (pGL3‐Basic‐IMPA2) and rs2075824 T (pGL3‐Basic‐IMPA2‐Mut) were constructed. Rs2075824 T allele promoter and C allele promoter were synthesized by Shanghai Novo Biotechnology Co., Ltd (Xuhui District, Shanghai, China) according to the sequences provided in another report by Ohnishi <italic>et al</italic>. <xref ref-type="ref" rid="jcmm13009-bib-0016">16</xref> and were verified by sequencing.</p>
<p>The synthesized IMPA2 promoters were directly cloned into MluI/XhoI site of pGL3‐Basic of vector. The structure of each construct was verified by sequencing. The vector pGL3‐control containing the SV40 promoter was used as a positive control.</p>
</sec>
<sec id="jcmm13009-sec-0007">
<title>Cell culture, transfection and luciferase assay</title>
<p>SH‐SY‐5Y (neuroblastoma cell line) was cultured in DMEM (Gibco, Gaithersburg, MD, USA) containing 10% heat‐inactivated foetal bovine serum (Gibco, Gaithersburg, MD, USA) in 10 cm culture dishes and were passaged at 60–70% confluence (1.8 × 10<sup>5</sup> cells/well) onto a 24‐well plate, 1 day before transfection. Transfections were performed using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions. 1.6 μg of plasmid DNA and 4 μl of Lipofectamine 2000 were mixed in 200 μl of OPTI‐DMEM. After 20‐min incubation, 1 ml of OPTI‐DMEM was added to individual wells and the Lipofectamine 2000/plasmid mixture was then added to each well containing cells. The plate was placed in a CO<sub>2</sub> incubator at 37°C. Medium was replaced 4–6 hrs after transfection. We performed the transcriptional assay using Renilla Luciferase Assay System (Promega, Madison, WI, USA). Transfected cells were washed with PBS 48 hrs after transfection and incubated in 200 μl of cell lysis buffer for 1 hr on ice. Next, 20 μl firefly was added into 20 μl cell lysate. The dual luciferase assay was carried out using a Modulus luminometer (Turner Biosystems, Sunnyvale, CA, USA).</p>
</sec>
<sec id="jcmm13009-sec-0008">
<title>Statistical analysis</title>
<p>Testing of genotypes for Hardy–Weinberg equilibrium (HWE) in all participants was determined by exact test included in the PLINK software package, version 1.07 <xref ref-type="ref" rid="jcmm13009-bib-0023">23</xref>. The threshold for significant deviation from HWE was set as 0.01. The differences in allele and genotype frequencies were analysed by use of the chi‐square text in PLINK software. The test of significance was two‐tailed, and alpha was set at 0.05. Bonferroni correction was applied for multiple comparisons of genotype frequencies, and alpha was set at 0.017. A logistic regression adjusted for age and gender was applied to evaluate how these factors influence the distribution of <italic>IMPA2</italic> polymorphisms. Effect of rs2075824 on the transcription activity of IMPA2 promoter was conducted with a paired <italic>t</italic>‐test. All tests were two‐tailed and statistical significance was defined as <italic>P</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="jcmm13009-sec-0009">
<title>Results</title>
<sec id="jcmm13009-sec-0010">
<title>IMPA2 SNPs and schizophrenia associations</title>
<p>All the six analysed SNPs were in HWE in the SCZ and control groups (<italic>P</italic> = 0.38 for rs971363, 0.27 for rs971362, 0.09 for rs2075824, 0.28 for rs111410794, 0.31 for rs111610121, 0.17 for rs45442994). As presented in Table <xref ref-type="table-wrap" rid="jcmm13009-tbl-0002">2</xref>, the genotype frequencies of rs2075824 were significantly different between SCZ patients and control groups (<italic>P</italic> = 4.1 × 10<sup>−4</sup>); the frequency of the T allele was higher in SCZ patients than in the control group (<italic>P</italic> = 5.6 × 10<sup>−5</sup>); after a 10,000 permutation correction, the differences were still significant (<italic>P</italic> = 1.4 × 10<sup>−4</sup> for genotype frequencies &amp; <italic>P</italic> = 1.1 × 10<sup>−4</sup> for allele frequencies). By performing Bonferroni correction (α = 0.017), the genotype frequencies of rs2075824 were significantly differ between SCZ patients and control groups. Furthermore, the polymorphism increased the risk of development of SCZ (OR = 1.26, 95% CI = 1.13–1.41). The rare allele T of rs2075824 contributed to disease susceptibility. There were no other significant disease risk associations.</p>
<table-wrap id="jcmm13009-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Association analysis of the six selected SNPs in 1397 patients with schizophrenia and 1285 mentally healthy controls</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Test model:SNP(A1/A2)<xref ref-type="fn" rid="jcmm13009-note-0003">*</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">SCZ freq. (%)</th>
<th align="char" colspan="1" rowspan="1" valign="top">CTR freq. (%)</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value<xref ref-type="fn" rid="jcmm13009-note-0003">†</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value<xref ref-type="fn" rid="jcmm13009-note-0003">‡</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">OR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="6" rowspan="1">rs971363(G;T)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:GG/GT/TT</td>
<td align="char" char="." colspan="1" rowspan="1">9.2/40.6/50.3</td>
<td align="char" char="." colspan="1" rowspan="1">8.7/41.9/49.4</td>
<td align="char" char="." colspan="1" rowspan="1">0.78</td>
<td align="char" char="." colspan="1" rowspan="1">0.86</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:G/T</td>
<td align="char" char="." colspan="1" rowspan="1">29.5/70.5</td>
<td align="char" char="." colspan="1" rowspan="1">29.6/70.4</td>
<td align="char" char="." colspan="1" rowspan="1">0.88</td>
<td align="char" char="." colspan="1" rowspan="1">0.86</td>
<td align="char" colspan="1" rowspan="1">0.99 (0.88–1.11)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs971362(T;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:TT/GT/GG</td>
<td align="char" char="." colspan="1" rowspan="1">10.7/46.0/43.4</td>
<td align="char" char="." colspan="1" rowspan="1">11.7/46.2/42.1</td>
<td align="char" char="." colspan="1" rowspan="1">0.65</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:T/G</td>
<td align="char" char="." colspan="1" rowspan="1">33.6/66.4</td>
<td align="char" char="." colspan="1" rowspan="1">34.8/65.2</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char="." colspan="1" rowspan="1">0.35</td>
<td align="char" colspan="1" rowspan="1">0.95 (0.85–1.06)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs2075824(T;C)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:TT/CT/CC</td>
<td align="char" char="." colspan="1" rowspan="1">15.4/44.9/39.7</td>
<td align="char" char="." colspan="1" rowspan="1">11.4/42.4/46.2</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>4.1 × 10</bold>
<sup><bold>−4</bold></sup>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>1.4 × 10</bold>
<sup><bold>−4</bold></sup>
</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:T/C</td>
<td align="char" char="." colspan="1" rowspan="1">37.8/62.2</td>
<td align="char" char="." colspan="1" rowspan="1">32.6/67.4</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>5.6 × 10</bold>
<sup><bold>−5</bold></sup>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>1.1 × 10</bold>
<sup><bold>−4</bold></sup>
</td>
<td align="char" colspan="1" rowspan="1">1.26 (1.13–1.41)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs111410794(C;T)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:CC/CT/TT</td>
<td align="char" char="." colspan="1" rowspan="1">16.6/45.5/37.9</td>
<td align="char" char="." colspan="1" rowspan="1">14.3/46.2/39.5</td>
<td align="char" char="." colspan="1" rowspan="1">0.25</td>
<td align="char" char="." colspan="1" rowspan="1">0.75</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:C/T</td>
<td align="char" char="." colspan="1" rowspan="1">39.4/60.6</td>
<td align="char" char="." colspan="1" rowspan="1">37.4/62.6</td>
<td align="char" char="." colspan="1" rowspan="1">0.15</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="char" colspan="1" rowspan="1">0.92 (0.83–1.03)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs111610121(A;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:AA/AG/GG</td>
<td align="char" char="." colspan="1" rowspan="1">8.7/38.5/52.8</td>
<td align="char" char="." colspan="1" rowspan="1">7.9/37.0/55.1</td>
<td align="char" char="." colspan="1" rowspan="1">0.45</td>
<td align="char" char="." colspan="1" rowspan="1">0.33</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:A/G</td>
<td align="char" char="." colspan="1" rowspan="1">28.0/72.0</td>
<td align="char" char="." colspan="1" rowspan="1">26.4/73.6</td>
<td align="char" char="." colspan="1" rowspan="1">0.21</td>
<td align="char" char="." colspan="1" rowspan="1">0.21</td>
<td align="char" colspan="1" rowspan="1">0.92 (0.82–1.04)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs45442994(A;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:AA/AG/GG</td>
<td align="char" char="." colspan="1" rowspan="1">4.8/37.1/58.1</td>
<td align="char" char="." colspan="1" rowspan="1">5.8/33.5/60.6</td>
<td align="char" char="." colspan="1" rowspan="1">0.11</td>
<td align="char" char="." colspan="1" rowspan="1">0.60</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:A/G</td>
<td align="char" char="." colspan="1" rowspan="1">23.3/76.7</td>
<td align="char" char="." colspan="1" rowspan="1">22.6/77.4</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="char" colspan="1" rowspan="1">1.04 (0.92–1.18)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="jcmm13009-note-0003">
<p>*A1/A2, indicates minor allele/major allele. <sup>†</sup>Significant <italic>P</italic>‐values (&lt;0.05) are in boldface. <sup>‡</sup>Global <italic>P</italic>‐value after 10,000 permutation correction for multiple testing. SCZ: schizophrenia; CTR: control; OR, odd ratio; 95% CI, 95% confidence interval.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="jcmm13009-sec-0011">
<title>Gender‐specific association</title>
<p>To examine whether gender‐specific differences are involved in the association, we analysed our data by stratifying males and females. We found that rs2075824 had significant allelic (<italic>P</italic> = 1.4 × 10<sup>−4</sup>) and genotypic (<italic>P</italic> = 9.5 × 10<sup>−4</sup>) associations with SCZ in all males (Table <xref ref-type="table-wrap" rid="jcmm13009-tbl-0003">3</xref>) but not in all females (Table <xref ref-type="table-wrap" rid="jcmm13009-tbl-0004">4</xref>). To verify these positive results, a 10,000 permutations test (Tables <xref ref-type="table-wrap" rid="jcmm13009-tbl-0002">2</xref>, <xref ref-type="table-wrap" rid="jcmm13009-tbl-0003">3</xref>, <xref ref-type="table-wrap" rid="jcmm13009-tbl-0004">4</xref>) was conducted and supports these associations. Logistic regression models adjusted for age and gender (<italic>P</italic> = 8.28 × 10<sup>−5</sup>, OR = 1.25, 95% CI = 1.12–1.40) confirmed that the ‘T’ allele of rs2075824 is consistently associated with an increased risk of SCZ (Table <xref ref-type="table-wrap" rid="jcmm13009-tbl-0005">5</xref>).</p>
<table-wrap id="jcmm13009-tbl-0003" orientation="portrait" position="float" xml:lang="en">
<label>Table 3</label>
<caption>
<p>Association analysis of the six selected SNPs in males with schizophrenia and healthy male controls</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Test model:SNP(A1/A2)<xref ref-type="fn" rid="jcmm13009-note-0004">*</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">SCZ freq. (%)</th>
<th align="char" colspan="1" rowspan="1" valign="top">CTR freq. (%)</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value<xref ref-type="fn" rid="jcmm13009-note-0004">†</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value<xref ref-type="fn" rid="jcmm13009-note-0004">‡</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">OR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="6" rowspan="1">rs971363(G;T)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:GG/GT/TT</td>
<td align="char" char="." colspan="1" rowspan="1">8.0/41.7/50.3</td>
<td align="char" char="." colspan="1" rowspan="1">9.4/43.1/47.5</td>
<td align="char" char="." colspan="1" rowspan="1">0.43</td>
<td align="char" char="." colspan="1" rowspan="1">0.60</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:G/T</td>
<td align="char" char="." colspan="1" rowspan="1">28.8/71.2</td>
<td align="char" char="." colspan="1" rowspan="1">30.9/69.1</td>
<td align="char" char="." colspan="1" rowspan="1">0.20</td>
<td align="char" char="." colspan="1" rowspan="1">0.13</td>
<td align="char" colspan="1" rowspan="1">0.91 (0.78–1.06)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs971362(T;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:TT/GT/GG</td>
<td align="char" char="." colspan="1" rowspan="1">10.3/47.9/41.7</td>
<td align="char" char="." colspan="1" rowspan="1">11.6/49.6/38.8</td>
<td align="char" char="." colspan="1" rowspan="1">0.46</td>
<td align="char" char="." colspan="1" rowspan="1">0.62</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:T/G</td>
<td align="char" char="." colspan="1" rowspan="1">34.3/65.7</td>
<td align="char" char="." colspan="1" rowspan="1">36.4/63.6</td>
<td align="char" char="." colspan="1" rowspan="1">0.23</td>
<td align="char" char="." colspan="1" rowspan="1">0.75</td>
<td align="char" colspan="1" rowspan="1">0.91 (0.79–1.06)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs2075824(T;C)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:TT/CT/CC</td>
<td align="char" char="." colspan="1" rowspan="1">16.1/45.2/38.8</td>
<td align="char" char="." colspan="1" rowspan="1">11.2/41.9/47.0</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>9.5 × 10</bold>
<sup><bold>−4</bold></sup>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>1.0 × 10</bold>
<sup><bold>−3</bold></sup>
</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:T/C</td>
<td align="char" char="." colspan="1" rowspan="1">38.6/61.4</td>
<td align="char" char="." colspan="1" rowspan="1">32.1/67.9</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>1.4 × 10</bold>
<sup><bold>−4</bold></sup>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>1.5 × 10</bold>
<sup><bold>−4</bold></sup>
</td>
<td align="char" colspan="1" rowspan="1">1.33 (1.15–1.55)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs111410794(C;T)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:CC/CT/TT</td>
<td align="char" char="." colspan="1" rowspan="1">16.6/45.6/37.8</td>
<td align="char" char="." colspan="1" rowspan="1">14.3/46.2/39.5</td>
<td align="char" char="." colspan="1" rowspan="1">0.43</td>
<td align="char" char="." colspan="1" rowspan="1">0.35</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:C/T</td>
<td align="char" char="." colspan="1" rowspan="1">39.4/60.6</td>
<td align="char" char="." colspan="1" rowspan="1">37.4/62.6</td>
<td align="char" char="." colspan="1" rowspan="1">0.25</td>
<td align="char" char="." colspan="1" rowspan="1">0.26</td>
<td align="char" colspan="1" rowspan="1">0.92 (0.80–1.06)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs111610121(A;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:AA/AG/GG</td>
<td align="char" char="." colspan="1" rowspan="1">8.8/38.5/52.7</td>
<td align="char" char="." colspan="1" rowspan="1">8.0/36.9/55.1</td>
<td align="char" char="." colspan="1" rowspan="1">0.61</td>
<td align="char" char="." colspan="1" rowspan="1">0.67</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:A/G</td>
<td align="char" char="." colspan="1" rowspan="1">28.1/71.9</td>
<td align="char" char="." colspan="1" rowspan="1">26.4/73.6</td>
<td align="char" char="." colspan="1" rowspan="1">0.32</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" colspan="1" rowspan="1">0.92 (0.79–1.08)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs45442994(A;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:AA/AG/GG</td>
<td align="char" char="." colspan="1" rowspan="1">4.4/36.9/58.7</td>
<td align="char" char="." colspan="1" rowspan="1">5.6/31.4/62.9</td>
<td align="char" char="." colspan="1" rowspan="1">0.06</td>
<td align="char" char="." colspan="1" rowspan="1">0.09</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:A/G</td>
<td align="char" char="." colspan="1" rowspan="1">22.8/77.2</td>
<td align="char" char="." colspan="1" rowspan="1">21.3/78.7</td>
<td align="char" char="." colspan="1" rowspan="1">0.32</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" colspan="1" rowspan="1">1.09 (0.92–1.29)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="jcmm13009-note-0004">
<p>*A1/A2, indicates minor allele/major allele. <sup>†</sup>Significant <italic>P</italic>‐values (&lt;0.05) are in boldface. <sup>‡</sup>Global <italic>P</italic>‐value after 10,000 permutation correction for multiple testing. SCZ: schizophrenia; CTR: control; OR, odd ratio; 95% CI, 95% confidence interval.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<table-wrap id="jcmm13009-tbl-0004" orientation="portrait" position="float" xml:lang="en">
<label>Table 4</label>
<caption>
<p>Association analysis of the six selected SNPs in females with schizophrenia and healthy female controls</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Test model:SNP(A1/A2)<xref ref-type="fn" rid="jcmm13009-note-0005">*</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">SCZ freq. (%)</th>
<th align="char" colspan="1" rowspan="1" valign="top">CTR freq. (%)</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value<xref ref-type="fn" rid="jcmm13009-note-0005">†</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">OR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="6" rowspan="1">rs971363(G;T)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:GG/GT/TT</td>
<td align="char" char="." colspan="1" rowspan="1">11.0/38.8/50.2</td>
<td align="char" char="." colspan="1" rowspan="1">7.9/40.3/51.9</td>
<td align="char" char="." colspan="1" rowspan="1">0.21</td>
<td align="char" char="." colspan="1" rowspan="1">0.22</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:G/T</td>
<td align="char" char="." colspan="1" rowspan="1">30.4/69.6</td>
<td align="char" char="." colspan="1" rowspan="1">28.0/72.0</td>
<td align="char" char="." colspan="1" rowspan="1">0.21</td>
<td align="char" char="." colspan="1" rowspan="1">0.21</td>
<td align="char" colspan="1" rowspan="1">1.13 (0.94–1.35)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs971362(T;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:TT/GT/GG</td>
<td align="char" char="." colspan="1" rowspan="1">11.2/43.0/45.9</td>
<td align="char" char="." colspan="1" rowspan="1">11.8/41.9/46.3</td>
<td align="char" char="." colspan="1" rowspan="1">0.90</td>
<td align="char" char="." colspan="1" rowspan="1">0.85</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:T/G</td>
<td align="char" char="." colspan="1" rowspan="1">32.6/67.4</td>
<td align="char" char="." colspan="1" rowspan="1">32.7/67.3</td>
<td align="char" char="." colspan="1" rowspan="1">0.96</td>
<td align="char" char="." colspan="1" rowspan="1">1.00</td>
<td align="char" colspan="1" rowspan="1">1.00 (0.83–1.19)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs2075824(T;C)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:TT/CT/CC</td>
<td align="char" char="." colspan="1" rowspan="1">14.4/44.4/41.2</td>
<td align="char" char="." colspan="1" rowspan="1">11.6/43.1/45.3</td>
<td align="char" char="." colspan="1" rowspan="1">0.25</td>
<td align="char" char="." colspan="1" rowspan="1">0.34</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:T/C</td>
<td align="char" char="." colspan="1" rowspan="1">36.6/63.4</td>
<td align="char" char="." colspan="1" rowspan="1">33.2/66.8</td>
<td align="char" char="." colspan="1" rowspan="1">0.09</td>
<td align="char" char="." colspan="1" rowspan="1">0.14</td>
<td align="char" colspan="1" rowspan="1">1.16 (0.98–1.38)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs111410794(C;T)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:CC/CT/TT</td>
<td align="char" char="." colspan="1" rowspan="1">16.5/45.5/37.9</td>
<td align="char" char="." colspan="1" rowspan="1">14.3/46.3/39.4</td>
<td align="char" char="." colspan="1" rowspan="1">0.58</td>
<td align="char" char="." colspan="1" rowspan="1">0.67</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:C/T</td>
<td align="char" char="." colspan="1" rowspan="1">39.3/60.7</td>
<td align="char" char="." colspan="1" rowspan="1">37.5/62.5</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char="." colspan="1" rowspan="1">0.40</td>
<td align="char" colspan="1" rowspan="1">0.93 (0.78–1.10)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs111610121(A;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:AA/AG/GG</td>
<td align="char" char="." colspan="1" rowspan="1">8.6/38.5/52.9</td>
<td align="char" char="." colspan="1" rowspan="1">7.9/37.0/55.1</td>
<td align="char" char="." colspan="1" rowspan="1">0.74</td>
<td align="char" char="." colspan="1" rowspan="1">0.86</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:A/G</td>
<td align="char" char="." colspan="1" rowspan="1">27.9/72.1</td>
<td align="char" char="." colspan="1" rowspan="1">26.4/73.6</td>
<td align="char" char="." colspan="1" rowspan="1">0.44</td>
<td align="char" char="." colspan="1" rowspan="1">0.50</td>
<td align="char" colspan="1" rowspan="1">1.93 (0.77–1.12)</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1">rs45442994(A;G)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Genotype:AA/AG/GG</td>
<td align="char" char="." colspan="1" rowspan="1">5.4/37.4/57.2</td>
<td align="char" char="." colspan="1" rowspan="1">6.1/36.3/57.6</td>
<td align="char" char="." colspan="1" rowspan="1">0.85</td>
<td align="char" char="." colspan="1" rowspan="1">1.00</td>
<td align="char" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Allele:A/G</td>
<td align="char" char="." colspan="1" rowspan="1">24.1/75.9</td>
<td align="char" char="." colspan="1" rowspan="1">24.2/75.8</td>
<td align="char" char="." colspan="1" rowspan="1">0.97</td>
<td align="char" char="." colspan="1" rowspan="1">0.86</td>
<td align="char" colspan="1" rowspan="1">1.00 (0.82–1.22)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="jcmm13009-note-0005">
<p>*A1/A2, indicates minor allele/major allele. <sup>†</sup>Global <italic>P</italic>‐value after 10,000 permutation correction for multiple testing. SCZ: schizophrenia; CTR: control; OR, odd ratio; 95% CI, 95% confidence interval.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<table-wrap id="jcmm13009-tbl-0005" orientation="portrait" position="float" xml:lang="en">
<label>Table 5</label>
<caption>
<p>Risk estimates using a logistic regression model for six SNPs in <italic>IMPA2</italic>
</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="2" valign="top">SNP</th>
<th align="char" colspan="1" rowspan="2" valign="top">Allele</th>
<th align="char" colspan="2" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Total (<italic>n</italic> = 2682)</th>
<th align="char" colspan="2" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Male (<italic>n</italic> = 1567)</th>
<th align="char" colspan="2" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">Female (<italic>n</italic> = 1115)</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value<xref ref-type="fn" rid="jcmm13009-note-0006">*</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">OR (95% CI)</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value<xref ref-type="fn" rid="jcmm13009-note-0006">†</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">OR (95% CI)</th>
<th align="char" colspan="1" rowspan="1" valign="top">
<italic>P</italic>‐value<xref ref-type="fn" rid="jcmm13009-note-0006">†</xref>
</th>
<th align="char" colspan="1" rowspan="1" valign="top">OR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">rs971363</td>
<td align="char" colspan="1" rowspan="1">G</td>
<td align="char" char="." colspan="1" rowspan="1">0.88</td>
<td align="char" char=" " colspan="1" rowspan="1">0.99 (0.88–1.11)</td>
<td align="char" char="." colspan="1" rowspan="1">0.17</td>
<td align="char" char=" " colspan="1" rowspan="1">0.90 (0.77–1.05)</td>
<td align="char" char="." colspan="1" rowspan="1">0.19</td>
<td align="char" char=" " colspan="1" rowspan="1">1.13 (0.94–1.35)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs971362</td>
<td align="char" colspan="1" rowspan="1">T</td>
<td align="char" char="." colspan="1" rowspan="1">0.37</td>
<td align="char" char=" " colspan="1" rowspan="1">0.95 (0.85–1.06)</td>
<td align="char" char="." colspan="1" rowspan="1">0.18</td>
<td align="char" char=" " colspan="1" rowspan="1">0.90 (0.77–1.05)</td>
<td align="char" char="." colspan="1" rowspan="1">0.97</td>
<td align="char" char=" " colspan="1" rowspan="1">1.00 (0.84–1.19)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs2075824</td>
<td align="char" colspan="1" rowspan="1">T</td>
<td align="char" char="." colspan="1" rowspan="1">8.28 × 10<sup>−5</sup>
</td>
<td align="char" char=" " colspan="1" rowspan="1">1.25 (1.12–1.40)</td>
<td align="char" char="." colspan="1" rowspan="1">1.05 × 10<sup>−4</sup>
</td>
<td align="char" char=" " colspan="1" rowspan="1">1.33 (1.15–1.54)</td>
<td align="char" char="." colspan="1" rowspan="1">0.14</td>
<td align="char" char=" " colspan="1" rowspan="1">1.14 (0.96–1.35)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs111410794</td>
<td align="char" colspan="1" rowspan="1">C</td>
<td align="char" char="." colspan="1" rowspan="1">0.15</td>
<td align="char" char=" " colspan="1" rowspan="1">1.08 (0.06–0.97)</td>
<td align="char" char="." colspan="1" rowspan="1">0.25</td>
<td align="char" char=" " colspan="1" rowspan="1">1.09 (0.94–1.25)</td>
<td align="char" char="." colspan="1" rowspan="1">0.38</td>
<td align="char" char=" " colspan="1" rowspan="1">1.08 (0.91–1.28)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs111610121</td>
<td align="char" colspan="1" rowspan="1">A</td>
<td align="char" char="." colspan="1" rowspan="1">0.21</td>
<td align="char" char=" " colspan="1" rowspan="1">1.08 (0.96–1.21)</td>
<td align="char" char="." colspan="1" rowspan="1">0.32</td>
<td align="char" char=" " colspan="1" rowspan="1">1.08 (0.93–1.26)</td>
<td align="char" char="." colspan="1" rowspan="1">0.44</td>
<td align="char" char=" " colspan="1" rowspan="1">1.08 (0.90–1.29)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs45442994</td>
<td align="char" colspan="1" rowspan="1">A</td>
<td align="char" char="." colspan="1" rowspan="1">0.53</td>
<td align="char" char=" " colspan="1" rowspan="1">1.04 (0.92–1.18)</td>
<td align="char" char="." colspan="1" rowspan="1">0.28</td>
<td align="char" char=" " colspan="1" rowspan="1">1.10 (0.93–1.30)</td>
<td align="char" char="." colspan="1" rowspan="1">0.86</td>
<td align="char" char=" " colspan="1" rowspan="1">0.98 (0.81–1.19)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="jcmm13009-note-0006">
<p>*<italic>P</italic>‐values in the logistic regression model, adjusted by gender and age. <sup>†</sup>
<italic>P</italic>‐values in the logistic regression model, adjusted by age.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>The other polymorphisms did not display a significant difference in the distributions of genotypes and alleles between the case and control group, even when stratified by gender (Tables <xref ref-type="table-wrap" rid="jcmm13009-tbl-0002">2</xref>, <xref ref-type="table-wrap" rid="jcmm13009-tbl-0003">3</xref>, <xref ref-type="table-wrap" rid="jcmm13009-tbl-0004">4</xref>). Linkage disequilibrium estimation for all SNPs was not performed because only rs2075824 yielded a significant association.</p>
</sec>
<sec id="jcmm13009-sec-0012">
<title>The rs2075824 T/C polymorphism affecting the transcription activation of IMPA2 promoter</title>
<p>To evaluate the effects of rs2075824 T/C in IMPA2 promoter region on transcription activity, we prepared two reporter plasmids carrying the luciferase gene under the control of the IMPA2 promoter. Each of the reporter plasmids was transfected into the human neuroblastoma cell line SH‐SY‐5Y. As shown in Figure <xref ref-type="fig" rid="jcmm13009-fig-0001">1</xref>, luciferase activity derived from the rs2075824 T promoter was higher than that from the rs2075824 C promoter (<italic>P</italic> &lt; 0.01), suggesting that the rs2075824 T promoter may result in enhanced promoter activity in the brain.</p>
<fig fig-type="Figure" id="jcmm13009-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Effect of rs2075824 T/C polymorphism on the transcription activity of <styled-content style="fixed-case">IMPA</styled-content>2 promoter. <styled-content style="fixed-case">SH</styled-content>‐<styled-content style="fixed-case">SY</styled-content>‐5Y cells were transiently transfected with <styled-content style="fixed-case">pGL</styled-content>3‐Basic‐<styled-content style="fixed-case">IMPA</styled-content>2 (<styled-content style="fixed-case">IMPA</styled-content>2 promoter with rs2075824 C), <styled-content style="fixed-case">pGL</styled-content>3‐Basic‐<styled-content style="fixed-case">IMPA</styled-content>2‐Mut (<styled-content style="fixed-case">IMPA</styled-content>2 promoter with rs2075824 T), or <styled-content style="fixed-case">pGL</styled-content>3‐Basic. The relative luciferase activity is represented as the ratio of the activity to that of <styled-content style="fixed-case">pGL</styled-content>3‐Basic. Data represent the average ± S.D. of triplicate samples. A representative result of three independent experiments is shown. **<italic>P</italic> &lt; 0.01; ***<italic>P</italic> &lt; 0.005, as determined by a paired <italic>t</italic>‐test.</p>
</caption>
<graphic id="nlm-graphic-1" xlink:href="JCMM-21-658-g001"></graphic>
</fig>
</sec>
</sec>
<sec id="jcmm13009-sec-0013">
<title>Discussion</title>
<p>Myo‐inositol monophosphatase 2 has been considered a functional candidate gene for SCZ because it was presumed to be involved in the protein kinase C signalling pathway, which regulates multiple neuronal processes implicated in mood regulation <xref ref-type="ref" rid="jcmm13009-bib-0024">24</xref>. It encodes myo‐inositol monophosphatase 2 (IMPase), which catalyses the final step in the inositol recycling by dephosphorylating myo‐inositol monophosphate to regenerate free inositol <xref ref-type="ref" rid="jcmm13009-bib-0017">17</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0025">25</xref>. An abnormality of inositol availability has been observed in specific brain regions of patients with SCZ <xref ref-type="ref" rid="jcmm13009-bib-0026">26</xref>. In addition, IMPase is a putative target for lithium <xref ref-type="ref" rid="jcmm13009-bib-0027">27</xref>, which has been used in psychiatric clinical treatment for over a century.</p>
<p>Several previous studies have investigated the genetic association and function of <italic>IMPA2</italic>
<xref ref-type="ref" rid="jcmm13009-bib-0014">14</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0015">15</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0016">16</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0018">18</xref>. Sjoholt <italic>et al</italic>. described a family‐based association study in a Palestinian‐Arab population in which SNPs in the promoter region of <italic>IMPA2</italic> were associated with bipolar disorder <xref ref-type="ref" rid="jcmm13009-bib-0015">15</xref>. The association was replicated by Ohnishi <italic>et al</italic>. in a Japanese population, and was further substantiated by functional studies that suggested transcriptional effects of a promoter haplotype <italic>in vitro</italic>
<xref ref-type="ref" rid="jcmm13009-bib-0016">16</xref>. The only association study between <italic>IMPA2</italic> and SCZ was conducted by Yoshikawa <italic>et al</italic>. in Japanese individuals; the SNPs rs111610121 (in the promoter region), rs2075825 (in exon 6), and rs45442994 (in intron 1) were positively associated with the disorder <xref ref-type="ref" rid="jcmm13009-bib-0014">14</xref>.</p>
<p>To assess the role of <italic>IMPA2</italic> in SCZ in Han Chinese, we carried out a genetic association study. In this study, a total of six SNPs were genotyped for association analyses in 1397 patients with SCZ and 1285 controls. We observed that rs2075824 was significantly associated with SCZ (<italic>P</italic> = 1.4 × 10<sup>−4</sup>); even after correcting for multiple testing and adjusting for gender and age, the genetic effect on SCZ remained significant. In addition, prior studies revealed the same SNP contributed to risk for bipolar disorder in Japanese and Palestinian Arab individuals. Indeed, <italic>IMPA2</italic> may participate in the development of SCZ and bipolar disorder and its promoter may be a hot spot harbouring <italic>IMPA2</italic> variants. However, whether/how the variation affected IMPase expression and inositol synthesis and lead to the SCZ phenotype remains to be explored. This prompted us to examine whether rs2075824 of IMPA2 contributed to risk for SCZ by elevating transcription activity in Han Chinese. Our results suggest that the T allele of rs2075824 was a risk factor for SCZ and may result in enhanced promoter activity in the brain; however, allele‐specific expression studies are needed to determine the results and illuminate the biological mechanisms. According to the functional researches on other loci or diseases reported before <xref ref-type="ref" rid="jcmm13009-bib-0016">16</xref>, <xref ref-type="ref" rid="jcmm13009-bib-0018">18</xref>, the mechanisms maybe the differences in binding affinity of alleles with transcription factors or by interacting with other genes nearby.</p>
<p>According to NCBI database, rs2075824 is very common in CHB (Han Chinese in Beijing, China) + JPI (Japanese in Tokyo, Japan) and CEU (Utah residents with ancestry from northern and western Europe), the minor allele frequencies are 0.5 and 0.16, respectively (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2075824">http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2075824</ext-link>). However, to our knowledge, around 30 SCZ‐associated loci have been identified through GWAS; no association of rs2075824 with SCZ was observed in other populations. The most important limiting factor is the sample size.</p>
<p>The relatively small sample size is also a limitation of our study; another limitation is the incomplete phenotypic characterization of the population. From the beginning of participant collection, we tried to collect more participants and more characteristics (age, gender, familial liability to psychotic, illness characteristics, index episode symptoms, response to treatment, socioeconomic or other characteristics, <italic>etc</italic>.), however, considering the characteristics of SCZ patients (①Most of the participants are outpatients who have great mobility and are difficult to track; ②The treatment compliances of SCZ patients were so poor that medications are not standardized), it is difficult to achieve. However, the results of this article sparked us to further study. Currently, we are trying to investigate the biological mechanism of the rise in transcriptional activity <italic>in vitro</italic>, so as to make up the shortcomings above.</p>
<p>In the present study, we also detected a gender‐specific association for IMPA2 and SCZ contributing to the hypothesis that there are differences between men and women regarding the etiology of SCZ <xref ref-type="ref" rid="jcmm13009-bib-0003">3</xref>. However, this result needs to be replicated in different independent samples, since there is a possibility of population bias, the limited sample size for individual genders is not large enough, and a gender‐genotype interaction has not been formally tested <xref ref-type="ref" rid="jcmm13009-bib-0028">28</xref>. Yoshikawa <italic>et al</italic>. discovered an association between rs111610121 and rs45442994 with SCZ in Japanese individuals; this association was not replicated in our Han Chinese population. The discordance may stem from the ethnic differences exist between Chinese and Japanese peoples or the relatively small sample size in this or previous studies. Hence, there still needs further large‐scale replication studies and functional investigation.</p>
</sec>
<sec id="jcmm13009-sec-0014">
<title>Conclusions</title>
<p>In summary, this study found that the T allele of rs2075824 in <italic>IMPA2</italic> promoter region possibly contributed to risk for SCZ in Han Chinese individuals by elevating transcription, providing evidence for the hypothesis that some susceptibility may be common to both SCZ and bipolar disorder. Furthermore, the findings imply a putative, gender‐dependent relationship between the <italic>IMPA2</italic> gene and SCZ. Additional functional analyses are necessary to fully elucidate the effects of <italic>IMPA2</italic> polymorphisms and their implication on inositol pathway regulation.</p>
</sec>
<sec id="jcmm13009-sec-0016">
<title>Conflicts of interest</title>
<p>The authors declare that they have no conflicts of interest.</p>
</sec>
</body>
<back>
<ack id="jcmm13009-sec-0015">
<title>Acknowledgements</title>
<p>This study was supported by the National Science Foundation of China (81273276, 81302551 and 81471593), Clinical Auxiliary Departments Construction Project of Shanghai Shen‐Kang Hospital Development Center (SHDC22014005), Shanghai Natural Science fund (14411963200), and Shanghai Municipal Science and Technology innovation action plan (15431901900). L.L., J.L., S.H. and H.R.D. participated in the study design, data analysis, and manuscript preparation. H.R.D., J.L. and J.M.Y. participated in recruiting patients. J.L., S.H., L.H.L., J.W., X.P. and H.R.D. contributed to genotyping and IMPA2 promoter assay. H.X., F.L. and Y.P.W. contributed to the collection of data. All the authors proofed and approved the final manuscript.</p>
</ack>
<ref-list content-type="cited-references" id="jcmm13009-bibl-0001">
<title>References</title>
<ref id="jcmm13009-bib-0001">
<label>1</label>
<mixed-citation id="jcmm13009-cit-0001" publication-type="journal">
<string-name>
<surname>Mueser</surname>
<given-names>KT</given-names>
</string-name>, <string-name>
<surname>McGurk</surname>
<given-names>SR</given-names>
</string-name>. <article-title>Schizophrenia</article-title>. <source/>Lancet. <year>2004</year>; <volume>363</volume>: <fpage>2063</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">15207959</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0002">
<label>2</label>
<mixed-citation id="jcmm13009-cit-0002" publication-type="journal">
<string-name>
<surname>Yuan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jin</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Qin</surname>
<given-names>HD</given-names>
</string-name>, <italic>et al</italic>
<article-title>Replication study confirms link between TSPAN18 mutation and schizophrenia in Han Chinese</article-title>. <source/>PLoS ONE. <year>2013</year>; <volume>8</volume>: <fpage>e58785</fpage>.<pub-id pub-id-type="pmid">23505562</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0003">
<label>3</label>
<mixed-citation id="jcmm13009-cit-0003" publication-type="journal">
<string-name>
<surname>Power</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Kyaga</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Uher</surname>
<given-names>R</given-names>
</string-name>, <italic>et al</italic>
<article-title>Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse <italic>vs</italic> their unaffected siblings</article-title>. <source/>JAMA Psychiatry. <year>2013</year>; <volume>70</volume>: <fpage>22</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="pmid">23147713</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0004">
<label>4</label>
<mixed-citation id="jcmm13009-cit-0004" publication-type="journal">
<string-name>
<surname>Lichtenstein</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Yip</surname>
<given-names>BH</given-names>
</string-name>, <string-name>
<surname>Bjork</surname>
<given-names>C</given-names>
</string-name>, <italic>et al</italic>
<article-title>Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population‐based study</article-title>. <source/>Lancet. <year>2009</year>; <volume>373</volume>: <fpage>234</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">19150704</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0005">
<label>5</label>
<mixed-citation id="jcmm13009-cit-0005" publication-type="journal">
<string-name>
<surname>Conus</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Macneil</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>McGorry</surname>
<given-names>PD</given-names>
</string-name>. <article-title>Public health significance of bipolar disorder: implications for early intervention and prevention</article-title>. <source/>Bipolar Disord. <year>2014</year>; <volume>16</volume>: <fpage>548</fpage>–<lpage>56</lpage>.<pub-id pub-id-type="pmid">24127825</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0006">
<label>6</label>
<mixed-citation id="jcmm13009-cit-0006" publication-type="journal">
<string-name>
<surname>Bourne</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Aydemir</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Balanza‐Martinez</surname>
<given-names>V</given-names>
</string-name>, <italic>et al</italic>
<article-title>Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis</article-title>. <source/>Acta Psychiatr Scand. <year>2013</year>; <volume>128</volume>: <fpage>149</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">23617548</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0007">
<label>7</label>
<mixed-citation id="jcmm13009-cit-0007" publication-type="journal">
<string-name>
<surname>Berrettini</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Ferraro</surname>
<given-names>TN</given-names>
</string-name>, <string-name>
<surname>Goldin</surname>
<given-names>LR</given-names>
</string-name>, <italic>et al</italic>
<article-title>Chromosome 18 DNA markers and manic‐depressive illness: evidence for a susceptibility gene</article-title>. <source/>Proc Natl Acad Sci USA. <year>1994</year>; <volume>91</volume>: <fpage>5918</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">8016089</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0008">
<label>8</label>
<mixed-citation id="jcmm13009-cit-0008" publication-type="journal">
<string-name>
<surname>Schwab</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Hallmayer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lerer</surname>
<given-names>B</given-names>
</string-name>, <italic>et al</italic>
<article-title>Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis</article-title>. <source/>Am J Hum Genet. <year>1998</year>; <volume>63</volume>: <fpage>1139</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">9758604</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0009">
<label>9</label>
<mixed-citation id="jcmm13009-cit-0009" publication-type="journal">
<string-name>
<surname>Bowen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kirov</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gill</surname>
<given-names>M</given-names>
</string-name>, <italic>et al</italic>
<article-title>Linkage studies of bipolar disorder with chromosome 18 markers</article-title>. <source/>Am J Med Genet. <year>1999</year>; <volume>88</volume>: <fpage>503</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">10490707</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0010">
<label>10</label>
<mixed-citation id="jcmm13009-cit-0010" publication-type="journal">
<string-name>
<surname>Detera‐Wadleigh</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Badner</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Berrettini</surname>
<given-names>WH</given-names>
</string-name>, <italic>et al</italic>
<article-title>A high‐density genome scan detects evidence for a bipolar‐disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2</article-title>. <source/>Proc Natl Acad Sci USA. <year>1999</year>; <volume>96</volume>: <fpage>5604</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">10318931</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0011">
<label>11</label>
<mixed-citation id="jcmm13009-cit-0011" publication-type="journal">
<string-name>
<surname>Nothen</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Cichon</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rohleder</surname>
<given-names>H</given-names>
</string-name>, <italic>et al</italic>
<article-title>Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families</article-title>. <source/>Mol Psychiatry. <year>1999</year>; <volume>4</volume>: <fpage>76</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">10089014</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0012">
<label>12</label>
<mixed-citation id="jcmm13009-cit-0012" publication-type="journal">
<string-name>
<surname>Mukherjee</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Meera</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</string-name>, <italic>et al</italic>
<article-title>Evidence of linkage and association on 18p11.2 for psychosis</article-title>. <source/>Am J Med Genet B Neuropsychiatr Genet. <year>2006</year>; <volume>141B</volume>: <fpage>868</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">16941653</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0013">
<label>13</label>
<mixed-citation id="jcmm13009-cit-0013" publication-type="journal">
<string-name>
<surname>Yoshikawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Turner</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Esterling</surname>
<given-names>LE</given-names>
</string-name>, <italic>et al</italic>
<article-title>A novel human myo‐inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder</article-title>. <source/>Mol Psychiatry. <year>1997</year>; <volume>2</volume>: <fpage>393</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">9322233</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0014">
<label>14</label>
<mixed-citation id="jcmm13009-cit-0014" publication-type="journal">
<string-name>
<surname>Yoshikawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kikuchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>K</given-names>
</string-name>, <italic>et al</italic>
<article-title>Evidence for association of the myo‐inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples</article-title>. <source/>Mol Psychiatry. <year>2001</year>; <volume>6</volume>: <fpage>202</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">11317223</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0015">
<label>15</label>
<mixed-citation id="jcmm13009-cit-0015" publication-type="journal">
<string-name>
<surname>Sjoholt</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Ebstein</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Lie</surname>
<given-names>RT</given-names>
</string-name>, <italic>et al</italic>
<article-title>Examination of IMPA1 and IMPA2 genes in manic‐depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder</article-title>. <source/>Mol Psychiatry. <year>2004</year>; <volume>9</volume>: <fpage>621</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">14699425</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0016">
<label>16</label>
<mixed-citation id="jcmm13009-cit-0016" publication-type="journal">
<string-name>
<surname>Ohnishi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ohba</surname>
<given-names>H</given-names>
</string-name>, <italic>et al</italic>
<article-title>A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription</article-title>. <source/>Neuropsychopharmacology. <year>2007</year>; <volume>32</volume>: <fpage>1727</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">17251911</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0017">
<label>17</label>
<mixed-citation id="jcmm13009-cit-0017" publication-type="journal">
<string-name>
<surname>Yoshikawa</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Padigaru</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Karkera</surname>
<given-names>JD</given-names>
</string-name>, <italic>et al</italic>
<article-title>Genomic structure and novel variants of myo‐inositol monophosphatase 2 (IMPA2)</article-title>. <source/>Mol Psychiatry. <year>2000</year>; <volume>5</volume>: <fpage>165</fpage>–<lpage>71</lpage>.<pub-id pub-id-type="pmid">10822344</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0018">
<label>18</label>
<mixed-citation id="jcmm13009-cit-0018" publication-type="journal">
<string-name>
<surname>Yoon</surname>
<given-names>IS</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>PP</given-names>
</string-name>, <string-name>
<surname>Siu</surname>
<given-names>KP</given-names>
</string-name>, <italic>et al</italic>
<article-title>Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder</article-title>. <source/>Mol Psychiatry. <year>2001</year>; <volume>6</volume>: <fpage>678</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">11673796</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0019">
<label>19</label>
<mixed-citation id="jcmm13009-cit-0019" publication-type="journal">
<string-name>
<surname>Ramsey</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Schwarz</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Guest</surname>
<given-names>PC</given-names>
</string-name>, <italic>et al</italic>
<article-title>Distinct molecular phenotypes in male and female schizophrenia patients</article-title>. <source/>PLoS ONE. <year>2013</year>; <volume>8</volume>: <fpage>e78729</fpage>.<pub-id pub-id-type="pmid">24244349</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0020">
<label>20</label>
<mixed-citation id="jcmm13009-cit-0020" publication-type="journal">
<string-name>
<surname>Hasin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hatzenbuehler</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Keyes</surname>
<given-names>K</given-names>
</string-name>, <italic>et al</italic>
<article-title>Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM‐IV) and International Classification of Diseases, tenth edition (ICD‐10)</article-title>. <source/>Addiction. <year>2006</year>; <volume>101</volume> (<issue>Suppl. 1</issue>): <fpage>59</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">16930162</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0021">
<label>21</label>
<mixed-citation id="jcmm13009-cit-0021" publication-type="journal">
<string-name>
<surname>Maj</surname>
<given-names>M</given-names>
</string-name>. <article-title>Critique of the DSM‐IV operational diagnostic criteria for schizophrenia</article-title>. <source/>Br J Psychiatry. <year>1998</year>; <volume>172</volume>: <fpage>458</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">9828982</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0022">
<label>22</label>
<mixed-citation id="jcmm13009-cit-0022" publication-type="journal">
<string-name>
<surname>Carlson</surname>
<given-names>RV</given-names>
</string-name>, <string-name>
<surname>Boyd</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Webb</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>The revision of the Declaration of Helsinki: past, present and future</article-title>. <source/>Br J Clin Pharmacol. <year>2004</year>; <volume>57</volume>: <fpage>695</fpage>–<lpage>713</lpage>.<pub-id pub-id-type="pmid">15151515</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0023">
<label>23</label>
<mixed-citation id="jcmm13009-cit-0023" publication-type="journal">
<string-name>
<surname>Purcell</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Neale</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Todd‐Brown</surname>
<given-names>K</given-names>
</string-name>, <italic>et al</italic>
<article-title>PLINK: a tool set for whole‐genome association and population‐based linkage analyses</article-title>. <source/>Am J Hum Genet. <year>2007</year>; <volume>81</volume>: <fpage>559</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0024">
<label>24</label>
<mixed-citation id="jcmm13009-cit-0024" publication-type="journal">
<string-name>
<surname>Abrial</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Lucas</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Scarna</surname>
<given-names>H</given-names>
</string-name>, <italic>et al</italic>
<article-title>A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?</article-title>
<source/>Mol Neurobiol. <year>2011</year>; <volume>44</volume>: <fpage>407</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">21983961</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0025">
<label>25</label>
<mixed-citation id="jcmm13009-cit-0025" publication-type="journal">
<string-name>
<surname>Atack</surname>
<given-names>JR</given-names>
</string-name>. <article-title>Inositol monophosphatase, the putative therapeutic target for lithium</article-title>. <source/>Brain Res Brain Res Rev. <year>1996</year>; <volume>22</volume>: <fpage>183</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="pmid">8883919</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0026">
<label>26</label>
<mixed-citation id="jcmm13009-cit-0026" publication-type="journal">
<string-name>
<surname>Shimon</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sobolev</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Davidson</surname>
<given-names>M</given-names>
</string-name>, <italic>et al</italic>
<article-title>Inositol levels are decreased in postmortem brain of schizophrenic patients</article-title>. <source/>Biol Psychiatry. <year>1998</year>; <volume>44</volume>: <fpage>428</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">9777173</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0027">
<label>27</label>
<mixed-citation id="jcmm13009-cit-0027" publication-type="journal">
<string-name>
<surname>Berridge</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Downes</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Hanley</surname>
<given-names>MR</given-names>
</string-name>. <article-title>Neural and developmental actions of lithium: a unifying hypothesis</article-title>. <source/>Cell. <year>1989</year>; <volume>59</volume>: <fpage>411</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">2553271</pub-id></mixed-citation>
</ref>
<ref id="jcmm13009-bib-0028">
<label>28</label>
<mixed-citation id="jcmm13009-cit-0028" publication-type="journal">
<string-name>
<surname>Patsopoulos</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Tatsioni</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ioannidis</surname>
<given-names>JP</given-names>
</string-name>. <article-title>Claims of sex differences: an empirical assessment in genetic associations</article-title>. <source/>JAMA. <year>2007</year>; <volume>298</volume>: <fpage>880</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">17712072</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>